Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7543067rdf:typepubmed:Citationlld:pubmed
pubmed-article:7543067lifeskim:mentionsumls-concept:C0023434lld:lifeskim
pubmed-article:7543067lifeskim:mentionsumls-concept:C0242640lld:lifeskim
pubmed-article:7543067lifeskim:mentionsumls-concept:C0031437lld:lifeskim
pubmed-article:7543067lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:7543067lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:7543067lifeskim:mentionsumls-concept:C2347946lld:lifeskim
pubmed-article:7543067pubmed:issue2lld:pubmed
pubmed-article:7543067pubmed:dateCreated1995-9-5lld:pubmed
pubmed-article:7543067pubmed:abstractTextLymphocytes from patients affected by B-cell chronic lymphocytic leukemia (B-CLL) have frequently been shown to be positive for the multidrug resistance (MDR) phenotype. However, this phenotype does not seem to be responsible for the resistance to alkylating agents usually employed in the management of CLL.lld:pubmed
pubmed-article:7543067pubmed:languageenglld:pubmed
pubmed-article:7543067pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543067pubmed:citationSubsetIMlld:pubmed
pubmed-article:7543067pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543067pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543067pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543067pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543067pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543067pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543067pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543067pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543067pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543067pubmed:statusMEDLINElld:pubmed
pubmed-article:7543067pubmed:issn0390-6078lld:pubmed
pubmed-article:7543067pubmed:authorpubmed-author:GrassiBBlld:pubmed
pubmed-article:7543067pubmed:authorpubmed-author:AmbrogiFFlld:pubmed
pubmed-article:7543067pubmed:authorpubmed-author:PetriniMMlld:pubmed
pubmed-article:7543067pubmed:authorpubmed-author:TestaJJlld:pubmed
pubmed-article:7543067pubmed:authorpubmed-author:CaraccioloFFlld:pubmed
pubmed-article:7543067pubmed:authorpubmed-author:CapochianiEElld:pubmed
pubmed-article:7543067pubmed:authorpubmed-author:Di SimoneDDlld:pubmed
pubmed-article:7543067pubmed:issnTypePrintlld:pubmed
pubmed-article:7543067pubmed:volume80lld:pubmed
pubmed-article:7543067pubmed:ownerNLMlld:pubmed
pubmed-article:7543067pubmed:authorsCompleteYlld:pubmed
pubmed-article:7543067pubmed:pagination103-7lld:pubmed
pubmed-article:7543067pubmed:dateRevised2010-3-24lld:pubmed
pubmed-article:7543067pubmed:meshHeadingpubmed-meshheading:7543067-...lld:pubmed
pubmed-article:7543067pubmed:meshHeadingpubmed-meshheading:7543067-...lld:pubmed
pubmed-article:7543067pubmed:meshHeadingpubmed-meshheading:7543067-...lld:pubmed
pubmed-article:7543067pubmed:meshHeadingpubmed-meshheading:7543067-...lld:pubmed
pubmed-article:7543067pubmed:meshHeadingpubmed-meshheading:7543067-...lld:pubmed
pubmed-article:7543067pubmed:meshHeadingpubmed-meshheading:7543067-...lld:pubmed
pubmed-article:7543067pubmed:meshHeadingpubmed-meshheading:7543067-...lld:pubmed
pubmed-article:7543067pubmed:meshHeadingpubmed-meshheading:7543067-...lld:pubmed
pubmed-article:7543067pubmed:meshHeadingpubmed-meshheading:7543067-...lld:pubmed
pubmed-article:7543067pubmed:meshHeadingpubmed-meshheading:7543067-...lld:pubmed
pubmed-article:7543067pubmed:meshHeadingpubmed-meshheading:7543067-...lld:pubmed
pubmed-article:7543067pubmed:meshHeadingpubmed-meshheading:7543067-...lld:pubmed
pubmed-article:7543067pubmed:meshHeadingpubmed-meshheading:7543067-...lld:pubmed
pubmed-article:7543067pubmed:meshHeadingpubmed-meshheading:7543067-...lld:pubmed
pubmed-article:7543067pubmed:meshHeadingpubmed-meshheading:7543067-...lld:pubmed
pubmed-article:7543067pubmed:meshHeadingpubmed-meshheading:7543067-...lld:pubmed
pubmed-article:7543067pubmed:meshHeadingpubmed-meshheading:7543067-...lld:pubmed
pubmed-article:7543067pubmed:meshHeadingpubmed-meshheading:7543067-...lld:pubmed
pubmed-article:7543067pubmed:meshHeadingpubmed-meshheading:7543067-...lld:pubmed
pubmed-article:7543067pubmed:meshHeadingpubmed-meshheading:7543067-...lld:pubmed
pubmed-article:7543067pubmed:articleTitleGlutathione-S-transferase activity and multidrug resistance phenotype in chronic lymphocytic leukemia: do they have any clinical relevance?lld:pubmed
pubmed-article:7543067pubmed:affiliationClinica Medica 1, Università di Pisa, Italy.lld:pubmed
pubmed-article:7543067pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7543067pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed